glp 1 with payment plan Employer FAQs on the Rise of GLP-1 Drugs for Weight Loss and the Workplace Impact Are There Payment Plans for

Oral GLP-1s can produce an average weight loss of ~6%14%, depending on the medication: Rybelsus (semaglutide) produces nearly 6% weight loss in one year , according to a small study of adults with obesity

-Average weight loss of 8% at the 3mg dose at 56 weeks

Yet subcutaneous injections of recombinant GLP-1 were a disappointment in patients, falling short of prior results with intravenous GLP-1

Commercially insured patients show a similar trend: 36% who began GLP-1 therapy in 2024 did not add another drug within a year, a significant rise from 13% in 2020

Anecdotal clinical experience suggests that there is already widespread knowledge in the pediatric population about the GLP-1RA effectiveness as satiety medications aiding weight loss, not helped by apparent widespread use documented in the popular media

In this context, GLP-1 microbiome support is best understood as a systems-based approach that connects SCFA production, gut barrier stability, microbial diversity, and long-term metabolic resilience